Work

Efficacy and safety of the Janus kinase inhibitor baricitinib in children with rheumatic diseases

Year: 2025

Type: article

Source: Voprosy praktičeskoj pediatrii

DOI: 10.20953/1817-7646-2025-3-34-41

Authors: Е.А. Krekhova, T.M. Dvoryakovskaya, E.I. Alekseeva

Language: English

Topic: Autoimmune and Inflammatory Disorders Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414470977

FWCI:

Cites:

Cited by:

Related to: